The global self-administered drugs market is anticipated to grow at a significant CAGR during the forecast period (2022- 2028). Self-administered medication is administered by patients themselves to control blood pressure, blood glucose, and other chronic illnesses. Active lifestyles have prompted patients to take medications which saves time and avoids going to hospitals. The growing incidences of chronic disorders such as diabetes and CVD are primarily contributing to the growth of the market. The market is segmented based on the type and indication. Based on the type, the market is sub-segmented into tablets, syrups, creams, and injectables. Injectables pharmaceuticals are drug product delivery systems that are used as an alternative to oral drugs and are more effective owing to rapid relief. Injectable pharmaceuticals are passed into the human body through syringes to the bloodstream and other parts of the body.
Some players in the market include Bristol-Myers Squibb Co., Abbott Laboratories, Gilead Sciences, Inc., among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in 2021 Abbott Laboratories announced the acquisition of a medical device company, Walk Vascular LLC. This acquisition will expand the peripheral vascular offering of Abbott and will drive endovascular therapy solutions, thereby improving patient care. Further, in 2021, Pfizer Inc. announced to acquire Trillium Therapeutics Inc. Trillium Therapeutics which is a clinical-stage immune-oncology company that develops innovative therapies to treat cancer. Additionally, Novartis AG in 2020, acquired The Medicines Company. This acquisition will provide a unique opportunity to provide treatment to the world’s leading cause of disability and mortality with vaccines.
(Get 15% Discount on Buying this Report)
Get Sample Copy of Global Self-Administered Drug Marketat https://orionmarketreports.com/request-sample/?id=94433&submit=Request+Sample%0D%0A
Market Coverage
- The market number available for – 2021-2028
- Base year- 2021
- Forecast period- 2022-2028
- Segment Covered-
- By Type
- By Indication
- Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape-Bristol-Myers Squibb Co., Abbott Laboratories, Gilead Sciences, Inc., among others.
A full report is available at: https://orionmarketreports.com/global-self-administered-drug-market/94433/
Global Self-Administered Drug Market Report by Segment
By Product Type
- Tablets
- Syrups
- Creams
- Injectables
By Indication
- Pain Management
- CVD
- Osteoporosis
- Diabetes
- Others
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How has COVID-19 impacted the market?
- Deviation from the pre-COVID-19 forecast
- Most affected region and segment
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
About Us:
Orion Market Reports (OMR) endeavors to provide exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.
Media Contact:
Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404
